Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern
Rishi R. Goel, Mark M. Painter, Sokratis A. Apostolidis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
Alison Tarke, Camila H. Coelho, Zeli Zhang, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 847-859.e11
Open Access | Times Cited: 760
BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotype
Gisella Guerrera, Mario Picozza, Silvia D’Orso, et al.
Science Immunology (2021) Vol. 6, Iss. 66
Open Access | Times Cited: 200
mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants
Aurélien Sokal, Giovanna Barba‐Spaeth, I. Fernández, et al.
Immunity (2021) Vol. 54, Iss. 12, pp. 2893-2907.e5
Open Access | Times Cited: 125
COVID vaccine immunity is waning — how much does that matter?
Elie Dolgin
Nature (2021) Vol. 597, Iss. 7878, pp. 606-607
Open Access | Times Cited: 121
Durability of immune responses to the BNT162b2 mRNA vaccine
Mehul S. Suthar, Prabhu S. Arunachalam, Mengyun Hu, et al.
Med (2022) Vol. 3, Iss. 1, pp. 25-27
Open Access | Times Cited: 43
Covid-19 vaccination: evidence of waning immunity is overstated
Jake Scott, Aaron Richterman, Müge Çevik
BMJ (2021), pp. n2320-n2320
Open Access | Times Cited: 42
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine
Chiara Agrati, Concetta Castilletti, Delia Goletti, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 36
Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study
Awadhesh Kumar Singh, Sanjeev Phatak, Ritu Singh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 2, pp. 102424-102424
Open Access | Times Cited: 30
Should a third booster dose be scheduled after two doses of CoronaVac? A single‐center experience
Metin Yiğit, Aslınur Özkaya Parlakay, Yasemin Coşgun, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 287-290
Open Access | Times Cited: 39
SARS-CoV-2 vaccination induces immunological memory able to cross-recognize variants from Alpha to Omicron
Alison Tarke, Camila H. Coelho, Zeli Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 39
T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination
Marios Koutsakos, Wen Shi Lee, Adam K. Wheatley, et al.
Journal of Leukocyte Biology (2021) Vol. 111, Iss. 2, pp. 355-365
Open Access | Times Cited: 32
Perspectives on the dynamic implications of cellular senescence and immunosenescence on macrophage aging biology
Rohit Sharma
Biogerontology (2021) Vol. 22, Iss. 6, pp. 571-587
Closed Access | Times Cited: 30
Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia
Elise A. Chong, Kingsley Gideon Kumashie, Emeline R. Chong, et al.
The Journal of Infectious Diseases (2024)
Closed Access | Times Cited: 3
Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination
Dong Ho Jo, Dohsik Minn, Jaegyun Lim, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1145-1145
Open Access | Times Cited: 25
Distinct Homologous and Variant-Specific Memory B-Cell and Antibody Response Over Time After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccination
Iana H. Haralambieva, Jonathon M. Monroe, Inna G. Ovsyannikova, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 1, pp. 23-31
Open Access | Times Cited: 17
SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021
Andrew D. Marques, Scott Sherrill-Mix, J.K. Everett, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Optimizing effectiveness of COVID-19 vaccination: will laboratory stewardship play a role?
Giuseppe Lippi, Brandon Michael Henry, Mario Plebani
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 12, pp. 1885-1888
Open Access | Times Cited: 22
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants
Jeffrey Seow, Carl Graham, Sadie R. Hallett, et al.
Cell Reports (2022) Vol. 39, Iss. 5, pp. 110757-110757
Open Access | Times Cited: 15
SARS-CoV-2 Antibody and T Cell Response after a Third Vaccine Dose in Hemodialysis Patients Compared with Healthy Controls
Benedikt Simon, Harald Rubey, Martin Gromann, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 694-694
Open Access | Times Cited: 13
Pre-existing T cell immunity determines the frequency and magnitude of cellular immune response to two doses of mRNA vaccine against SARS-CoV-2
José L. Casado, Pilar Vizcarra, Johannes Häemmerle, et al.
Vaccine X (2022) Vol. 11, pp. 100165-100165
Open Access | Times Cited: 12
Adaptive immune responses and cytokine immune profiles in humans following prime and boost vaccination with the SARS-CoV-2 CoronaVac vaccine
Chan Wang, Songhao Yang, Liangwei Duan, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 12
ESGE and ESGENA Position Statement on gastrointestinal endoscopy and COVID-19: Updated guidance for the era of vaccines and viral variants
Ian M. Gralnek, Cesare Hassan, Alanna Ebigbo, et al.
Endoscopy (2021) Vol. 54, Iss. 02, pp. 211-216
Open Access | Times Cited: 16
Where do T cell subsets stand in SARS-CoV-2 infection: an update
Mohammad Tarique, Mohd Suhail, Huma Naz, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 11
Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination
Furong Qi, Yingyin Cao, Shuye Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Long Term Immune Response Produced by the SputnikV Vaccine
Ekaterina Martynova, Shaimaa Hamza, Ekaterina Garanina, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11211-11211
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top